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All too often the informed consent process is viewed by members of research teams as a
challenge of getting a parent or young person’s signature on a form. Informed consent is,
however, much more than a signed form. Rather, it is a process, often iterative, in which the
parent or young person is given sufficient information about a study in order that they can
make a truly informed decision about participation. Substantial effort is required in produc-
ing appropriately formatted and readable documents using plain language at about Grade
6 or 12-year old reading level. Achieving truly understood consent involves the researcher
spending significant one-on-one time with the parent or young person explaining in simple
language what is proposed and then using so-called repeat-back techniques to test the
understanding of the participants. This is critically important if the research involves ran-
domization to different treatments or use of a placebo arm and, in particular if the research
involves more than minimal risk.
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Obtaining consent from a parent for their child to participate in a
research study is often reduced to a process whereby the parent, or
young person, is given an explanation of the study and an Infor-
mation Package and the researcher or, more often, a member of the
research team then collects a signature for participation on a con-
sent form. While this description may sound somewhat extreme,
it is reflective of how consent is frequently collected. I argue that
consent, informed consent and understood consent have quite dif-
ferent meanings. The ideal goal of researchers recruiting subjects
for a research study should be understood consent.
Prospective research participants may only understand 30–80%
of the information in standard consent processes (1). As the goal
of understood consent is currently rarely achieved, it is necessary
to examine some of the contributing causes for this failure.
A major factor is that the focus of the consent process has
changed from serving the needs of the patient to satisfying
the medico-legal needs of institutions. Both institutions and
researchers need to comply with regulatory requirements which
now mandate the information that must be provided to a research
subject. A consequence of this change in focus has been that
Information/Consent packages for research studies have grown
in both length and complexity. This involves a significant trade-
off as it is well documented that as the length and complexity
of an Information/Consent Package increases, the comprehen-
sion of the potential participant decreases (2). It can also take
research staff significant time to explain these lengthy documents
and, if there are time constraints, this can lead inadequate expla-
nation and searching for understanding versus simply providing
the information.
The readability of the Information Package is also critical. From
the participant’s perspective, such documents need to be in plain
language and it is recommended that they be written at a Grade
6 or 12-year old reading level (3–5). The regulatory and medico-
legal needs of institutions typically win out over providing simple,
plain language information that is likely to best meet the needs of
the parent or participant.
PRE-CONDITIONS FOR RESEARCH ON CHILDREN
There are two fundamental pre-conditions that must be satisfied
for all research on children. Firstly, the research must be both sci-
entifically and ethically sound. Secondly, a clinical research study
must also have an appropriate balance of risk and potential benefit
and the number of subjects enrolled must be capable of answering
the scientific question (6).
Roth-Cline et al. enunciated the ethical principle of “scientific
necessity” in pediatric research (6). This principle holds that chil-
dren should not be enrolled in a clinical investigation unless it is
necessary to achieve an important scientific and/or public health
objective concerning the health and welfare of children. A corol-
lary is that children should not be enrolled in studies that are
duplicative or unlikely to yield important knowledge applicable to
children about the product or condition under investigation.
HOWMUCH INFORMATION TO PRESENT ABOUT THE
RESEARCH STUDY?
Increasingly, the content of consent documents is being mandated
by regulation, particularly, but not only, in the USA. These regu-
lations are weighted in favor of providing all relevant information
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to potential research participants. While, at one level, it is dif-
ficult to argue against this there are important consequences in
that the Information/Consent Package becomes quite long, often
being 20 pages or more in length. For example, The World Health
Organization has published an Informed Consent Form tem-
plate as a guide to investigators (7). Unfortunately, it is 11 pages
in length before the investigator has added their trial-specific
material.
In an Australian study, Beardsley et al. noted that in 5 years,
Australian clinical trial Informed Consent information packages
had increased from a median 7 pages in 2000 to 11 pages in 2005
(with a range of 7–21 pages) (8). Much of this lengthening was
attributed to legislative and regulatory information imposed by
Australian law, typically with patient safety in mind.
Albala et al. highlighted the inherent paradox in attempting to
use consent forms to convey ever-more-complete information to
potential research subjects and the subject’s ability to comprehend
the information (9).
There is convincing evidence that participant comprehension
decreases as the length of the document increases. Albala et al.
cited data showing that consent forms that are longer than four
pages are unlikely to be read (9) while Sharp has suggested that
consent forms longer than 1,000 words (four double-spaced pages)
are unlikely to be read (2).
There must be a balance between overwhelming potential par-
ticipants with too much information and giving them insufficient
information to make an informed choice. One suggested method
for dealing with this paradox is to use a layered approach to the
provision of information where a short readable précis is pre-
sented first before more detailed supplementary information. The
National Health Service National Research Ethics Service in the
U.K. suggests the participant information sheet be provided in
two parts (10). The first part should contain brief and clear infor-
mation on the essential elements of the specific study such as what
the research is about and what participants will have to do. A
second part should contain more detailed information.
There are ethical implications of giving people information
they cannot understand and act on, particularly, when the pre-
sumed goal of that information is to enable people to make an
informed choice about participation in a research study.
HOW TO PRESENT AND EXPLAIN INFORMATION ABOUT THE
PROPOSED RESEARCH STUDY?
This element is central to the process of obtaining understood con-
sent. There are two complementary processes involved in obtain-
ing understood consent; the presentation of the written material
and, importantly, the process or methods used to explain the mate-
rial such that the parent/young person or potential participant
truly understands what is being presented. Research has shown
that providing both written and verbal information leads to better
information recall than written or verbal information alone (11).
Before exploring the detail of these two elements, it is reason-
able to ask why giving someone a document to read is not, of itself,
sufficient for the purposes of consent. I have already alluded to
the inverse relationship between the length and complexity of the
documents and comprehension. Another critical factor is health
literacy.
IMPACT OF HEALTH LITERACY ON CONSENT PROCESSES
In 2007, the Australian Bureau of Statistics participated in an
international comparative study – the Adult Literacy and Life-
skills Survey (ALLS) (12). Health literacy is the degree to which
individuals have the capacity to obtain, process and understand
basic health information, and services needed to make appropri-
ate health decisions. The survey found that around 45% of the
adult population in Australia have “poor” or “very poor” health
literacy skills. Another key issue is “that you can’t tell by looking”
when it comes to predicting a parent’s reading skills and compre-
hension. Some individuals become very adept at covering up their
lack of skills in this domain. Kripalani et al. suggested that sub-
jects with low literacy be classed a vulnerable group for research
participation (13).
These issues may be of little consequence for low risk non-
invasive research but become highly relevant for research studies
that involve more than minimal risk or research studies in chil-
dren with life threatening conditions. In this situation, meticulous
attention must be given to ensuring the parents truly comprehend
the information before consent is taken.
Obviously these issues assume a larger dimension in the devel-
oping world where poor literacy is often widespread. Based on
this information, it is reasonable to assume that many parents in
a developing country would struggle to understand and appropri-
ately analyze a consent form without additional explanation and
assistance. Obtaining understood consent in these environments
can be extremely challenging. There has been negligible research in
this area. Bhutta emphasized the importance of senior members of
the research team with capacity to answer questions being involved
in the consent process and including communication experts (11).
Bhutta also addressed the issue of understood consent in devel-
oping countries and provided helpful suggestions on improving
consent processes. These include providing community infor-
mation sessions, a staged process for obtaining consent, using
innovative materials and processes and using alternative processes
for documenting consent such as making an audio recording (11).
In a comprehensive review, Campbell discusses the issue of
informed consent and, in particular, the issues of understanding
and voluntariness (14). Campbell observed that the understand-
ing of research concepts affects both developed and developing
settings and that the real focus should be on adapting the uni-
versal paradigms of research to local cultural norms, ideas and
literacy levels (14). Emanuel et al. similarly advocate that the eth-
ical requirements of biomedical research must be adapted to the
health, economic, cultural, and technological conditions in which
research is conducted (15).
THE PROCESS OF OBTAINING CONSENT
In this overall context, the previously mentioned differences
between consent, informed consent, and understood consent
become crucially important. A signed consent form is documen-
tary evidence of “consent” but gives no clue as to the process
whereby the consent was obtained. Getz in a survey of recent trial
participants found that one in seven participants stated that no one
from the research team reviewed the consent form with them (16).
Truly “understood consent” is obtained by presenting trial infor-
mation in a layered manner (17) with substantial one-on-one time
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spent by the researcher or a nominee and the parent/young per-
son or potential participant in which it is assumed that the person
may not have the capacity to read or comprehend complex writ-
ten material. “Informed consent” is a false half-way house between
these two positions. The goal of all researchers in recruiting sub-
jects should be truly “understood consent.” This is particularly so
in research that involves randomization or the use of a placebo arm
and, in particular if the research involves more than minimal risk.
A key element in preparing Information/Consent Packages is
to ensure that the documents are written and formatted in a way
that enhances their readability.
There is a growing body of literature on how best to obtain
consent. Titus and Keane provided useful guidance on assessing
parental understanding of informed consent (18). It was recom-
mended that the researcher ask the potential research participant
short questions after the research has been described and the
consent form read, in order to assess that the potential research
participant has at least a basic understanding of what the research
involves. Example questions included:
o Tell me in your own words what this study is all about.
o Tell me what you think will happen to you in this study.
o What do you expect to gain by taking part in this research?
o What risks might you experience by participating in the
research?
o What are your alternatives (other choices or options to partici-
pating in this research)?
The author acknowledges that this is a challenging proposition
even in developed countries and that the difficulties in developing
countries are much greater. The above represents an “aspira-
tional goal” that people in developing countries need to embrace
and use innovative, contextually appropriate methods to obtain
consent.
The U.S. Agency for Healthcare Research and Quality pub-
lished a report Making Health Care Safer: A Critical Analysis of
Patient Safety Practices that reviewed patient safety practices and
focused special attention on practices deserving of widespread
implementation (19). One of these practices was: “Asking patients
to recall and restate what they have been told during the informed
consent process.” This was an effort to ensure that patients not
only read and heard the informed consent, but more importantly,
understood the informed consent.
Further, the National Quality Forum (NQF), an organization
chartered to develop and implement a U.S. national strategy for
healthcare quality measurement and reporting, released a report,
Safe Practices for Better Healthcare, that endorsed healthcare prac-
tices aimed at improving patient safety throughout the healthcare
system (20). One of these was that all healthcare professionals
should ask patients to repeat or “teach back” what they have
been told by their provider during the informed consent dis-
cussion. This report has recently been updated and includes a
detailed evidence-based chapter on obtaining informed consent
(21). While using the combination of written and verbal explana-
tion is time consuming, the advantage of the “teach back” method
is that areas of poor comprehension can be identified allowing
further explanation to occur. Research staff may require special
training in the use of the “teach back” methodology. Using the
“teach back” methodology can also identify patients who, despite
repeated corrective feedback,have poor comprehension of the pro-
posed research. It is doubtful if informed consent can be obtained
from such patients. The combination of providing written infor-
mation along with verbal explanation and “teach back” questions
should also be applied to adolescents who are being asked to assent
to research participation.
Palmer et al. suggested that embedding explicit inquiries and re-
explanations during the process of information disclosure serves
both to model and emphasize for participants the notion that their
understanding is sincerely, rather than just symbolically, desired by
the researcher and their staff prior to study enrollment (22).
IMPLICATIONS FOR PEDIATRIC PULMONOLOGY: THE WAY
FORWARD
There are clear and specific implications of this argument for
pediatric pulmonology researchers.
The concept of understood consent is neither new nor novel
having been described for some time by Beauchamp and Childress
(23). However, progress in changing the consent process toward
understood consent has been inexorably slow.
Pediatric pulmonologists are drawn into this construct by
virtue of how they obtain consent for both investigational pro-
cedures and for research studies. Recognizing that children are
an inherently vulnerable group in regards to both clinical proce-
dures and as research subjects is central to the ethical conduct of
pediatric practice. The responsibility for ensuring that the child’s
parents or the young person truly understands the nature of the
clinical procedure or research as well as the potential risks lies with
the clinician or researcher.
It is time to move from the mindset of informed consent being
a signature on a page and instead embrace the ideal goal of under-
stood consent. This will involve changes to the way both clinical
and research material is prepared and presented and, in rela-
tion to research, much greater one-on-one interaction between
the research team and the potential participant. The communi-
cation process must be more interactive and, ideally, include the
“repeat back” methodologies described earlier. The use of cul-
turally and developmentally appropriate alternate technologies,
including posters, videos, etc. are to be encouraged as alternatives
to the conventional consent Information Package. While this may
be more time consuming, inclusion of these techniques will likely
identify gaps in understanding to be addressed and, if the ques-
tions and responses are documented, provide an auditable record
of a high standard consent process.
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